A randomized study comparing the use of the Ligaclip with bipolar energy to prevent lymphocele during laparoscopic pelvic lymphadenectomy for gynecologic cancer

被引:54
|
作者
Gallotta, Valerio [1 ]
Fanfani, Francesco [1 ]
Rossitto, Cristiano [1 ]
Vizzielli, Giuseppe [1 ]
Testa, Antonia [1 ]
Scambia, Giovanni [1 ]
Fagotti, Anna [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Div Gynecol Oncol, I-00168 Rome, Italy
关键词
gynecological malignancies; laparoscopic pelvic lymphadenectomy; lymphocele; pelvic lymphadenectomy; RADICAL HYSTERECTOMY; ABDOMINAL HYSTERECTOMY; NO DRAINAGE; COMPLICATIONS; SYSTEM; CLIPS;
D O I
10.1016/j.ajog.2010.06.053
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: This prospective randomized pilot study compared the use of the Ligaclip (Ethicon Endo-Surgery, Cincinnati, OH) with bipolar coagulation in preventing lymphoceles after laparoscopic pelvic lymphadenectomy for gynecologic cancer. STUDY DESIGN: Thirty patients with gynecologic malignancy, who had laparoscopic pelvic lymphadenectomy were randomly assigned for lymphadenectomy in 1 side of the pelvis using the Ligaclip, whereas, in the other side, the bipolar coagulation to seal lymphatic vessels was used. RESULTS: At ultrasound examination, we detected lymphocele in 10 patients (33%). Lymphocele developed in 9 (30%) patients on the side where laparoscopic pelvic lymphadenectomy was perfomed using bipolar coagulation, and in 1 (3.3%) patient on the side where laparoscopic pelvic lymphadenectomy was performed using the Ligaclip. Univariate analysis revealed that the Ligaclip's use compared with electrocoagulation in the laparoscopic pelvic lymphadenectomy is an independent predictive factor for development of lymphocele (P = .006). CONCLUSION: This study demonstrates that the use of the Ligaclip to close lymphatic vessels may reduce the incidence of lymphoceles in patients undergoing laparoscopic pelvic lymphadenectomy.
引用
收藏
页码:483.e1 / 483.e6
页数:6
相关论文
共 22 条
  • [21] A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Long, Meijun
    Jia, Weijuan
    Li, Shunrong
    Jin, Liang
    Wu, Jiannan
    Rao, Nanyan
    Feng, Huiyi
    Chen, Kai
    Deng, Heran
    Liu, Fengtao
    Su, Fengxi
    Song, Erwei
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 705 - 712
  • [22] A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Meijun Long
    Weijuan Jia
    Shunrong Li
    Liang Jin
    Jiannan Wu
    Nanyan Rao
    Huiyi Feng
    Kai Chen
    Heran Deng
    Fengtao Liu
    Fengxi Su
    Erwei Song
    Breast Cancer Research and Treatment, 2011, 127